Reports of breast cancer drug trials in the scientific literature are far from fair and balanced, according to researchers at the University of Toronto this week

The group published a study in Annals of Oncology yesterday showing that outcomes from phase III breast cancer trials are widely reported with both spin and bias.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.